P-gp and taxanes

Documenti analoghi

• Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes
  di: van Eijk, Maarten, et al.
  Pubblicazione: (2019)
• P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy
  di: Sankatsing, Sanjay U. C., et al.
  Pubblicazione: (2004)
• Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
  di: Hendrikx, Jeroen J M A, et al.
  Pubblicazione: (2020)
• Fixed Dosing of Monoclonal Antibodies in Oncology
  di: Hendrikx, Jeroen J.M.A., et al.
  Pubblicazione: (2017)
• P-Glycoprotein Limits Oral Availability, Brain Penetration, and Toxicity of an Anionic Drug, the Antibiotic Salinomycin
  di: Lagas, Jurjen S., et al.
  Pubblicazione: (2008)